{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T19:09:03Z","timestamp":1788808143939,"version":"build-2803163510"},"reference-count":14,"publisher":"Oxford University Press (OUP)","license":[{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"funder":[{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","award":["JP21H04828"],"award-info":[{"award-number":["JP21H04828"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000646","name":"JSPS","doi-asserted-by":"publisher","award":["JP26H02447"],"award-info":[{"award-number":["JP26H02447"]}],"id":[{"id":"10.13039\/501100000646","id-type":"DOI","asserted-by":"publisher"}]},{"name":"AMED Research on Development of New Drugs","award":["JP26ak0101275"],"award-info":[{"award-number":["JP26ak0101275"]}]},{"name":"AMED Research on Development of New Drugs","award":["JP26ak0101263"],"award-info":[{"award-number":["JP26ak0101263"]}]},{"name":"Practical Research for Innovative Cancer Control from AMED","award":["JP26ck0106946"],"award-info":[{"award-number":["JP26ck0106946"]}]},{"name":"Practical Research for Innovative Cancer Control from AMED","award":["JP26ck0106906"],"award-info":[{"award-number":["JP26ck0106906"]}]},{"name":"AMED-PRIME","award":["JP26gm7010010"],"award-info":[{"award-number":["JP26gm7010010"]}]},{"name":"JST FOREST","award":["JPMJFR2118"],"award-info":[{"award-number":["JPMJFR2118"]}]},{"name":"Takeda Science Foundation and the Canon Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1093\/jjco\/hyag149","type":"journal-article","created":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:50:39Z","timestamp":1787313039000},"source":"Crossref","is-referenced-by-count":0,"title":["Emerging perspectives on RNA-based and RNA-targeted therapeutics in oncology"],"prefix":"10.1093","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0664-7281","authenticated-orcid":false,"given":"Akihide","family":"Yoshimi","sequence":"first","affiliation":[{"name":"Division of Cancer RNA Research, National Cancer Center Research Institute , Chuo-ku ,","place":["Japan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,7]]},"reference":[{"key":"2026090714582421200_ref1","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1038\/s41573-025-01237-x","article-title":"RNA chemistry and therapeutics","volume":"24","author":"Wang","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"2026090714582421200_ref2","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41573-024-00943-2","article-title":"Frameworks for transformational breakthroughs in RNA-based medicines","volume":"23","author":"Androsavich","year":"2024","journal-title":"Nat Rev Drug Discov"},{"key":"2026090714582421200_ref3","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jjco\/hyag017","article-title":"Advances in antisense oligonucleotide treatment for cancer","volume":"56","author":"Zhu","year":"2026","journal-title":"Jpn J Clin Oncol"},{"key":"2026090714582421200_ref4","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/S0140-6736(23)01724-5","article-title":"Imetelstat in patients with lower-risk myelodysplastic syndromes who have relapsed or are refractory to erythropoiesis-stimulating agents (IMerge): a multinational, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"403","author":"Platzbecker","year":"2024","journal-title":"Lancet."},{"key":"2026090714582421200_ref5","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/jjco\/hyaf199","article-title":"Technological advances in mRNA delivery and engineering for therapeutic cancer vaccines","volume":"56","author":"Uchida","year":"2026","journal-title":"Jpn J Clin Oncol"},{"key":"2026090714582421200_ref6","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1016\/S0140-6736(23)02268-7","article-title":"Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study","volume":"403","author":"Weber","year":"2024","journal-title":"Lancet."},{"key":"2026090714582421200_ref7","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyag099","article-title":"Progress in siRNA nucleic acid therapeutics and challenges in their application to cancer treatment","author":"Ui-Tei","year":"2026","journal-title":"Jpn J Clin Oncol"},{"key":"2026090714582421200_ref8","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1093\/jjco\/hyag018","article-title":"RNA modifications in cancer and their detection: a review","volume":"56","author":"Yu","year":"2026","journal-title":"Jpn J Clin Oncol"},{"key":"2026090714582421200_ref9","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1016\/j.cell.2017.05.045","article-title":"Dynamic RNA modifications in gene expression regulation","volume":"169","author":"Roundtree","year":"2017","journal-title":"Cell."},{"key":"2026090714582421200_ref10","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/s41568-024-00750-2","article-title":"Steering research on mRNA splicing in cancer towards clinical translation","volume":"24","author":"Anczukow","year":"2024","journal-title":"Nat Rev Cancer"},{"key":"2026090714582421200_ref11","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1111\/cas.15213","article-title":"Aberrant RNA splicing and therapeutic opportunities in cancers","volume":"113","author":"Yamauchi","year":"2022","journal-title":"Cancer Sci"},{"key":"2026090714582421200_ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jjco\/hyag140","article-title":"Splicing modulation as an emerging therapeutic strategy in cancer: molecular mechanisms, clinical development, and future perspectives","author":"Jingele","journal-title":"Jpn J Clin Oncol"},{"key":"2026090714582421200_ref13","doi-asserted-by":"publisher","first-page":"919","DOI":"10.1093\/jjco\/hyag065","article-title":"Cellular plasticity of cancer: roles of biomolecular condensates and ecDNA","volume":"56","author":"Sugimoto","year":"2026","journal-title":"Jpn J Clin Oncol"},{"key":"2026090714582421200_ref14","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41568-024-00669-8","article-title":"Extrachromosomal DNA in cancer","volume":"24","author":"Yan","year":"2024","journal-title":"Nat Rev Cancer"}],"container-title":["Japanese Journal of Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jjco\/advance-article-pdf\/doi\/10.1093\/jjco\/hyag149\/70985243\/hyag149.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jjco\/advance-article-pdf\/doi\/10.1093\/jjco\/hyag149\/70985243\/hyag149.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T18:58:26Z","timestamp":1788807506000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jjco\/advance-article\/doi\/10.1093\/jjco\/hyag149\/8787470"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,7]]},"references-count":14,"URL":"https:\/\/doi.org\/10.1093\/jjco\/hyag149","relation":{},"ISSN":["1465-3621"],"issn-type":[{"value":"1465-3621","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,7]]},"article-number":"hyag149"}}